We confirmed this notion analyzing breast cancer patients’ overall survival (OS) from a different dataset37 containing different clinical conditions and subtypes, including tumoral grade, ER/PR/HER2, lymph-node status, etc. (Total) (Fig. 5a). The gene discussed is ERBB2; the disease is breast cancer.